Quick Answer
Tyra Biosciences, Inc. reported Net Income of -$119.95 million for fiscal year 2025.
Tyra Biosciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$119.95M | -38.7% |
| 2024 | -$86.48M | -25.1% |
| 2023 | -$69.13M | -25.0% |
| 2022 | -$55.33M | -110.4% |
| 2021 | -$26.29M | -181.6% |
| 2020 | -$9.34M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$29.87M | -24.4% | -6.3% |
| June 30, 2025 | -$28.10M | -50.2% | +0.2% |
| March 31, 2025 | -$28.15M | -54.7% | -17.2% |
| September 30, 2024 | -$24.02M | -13.5% | -28.4% |
| June 30, 2024 | -$18.70M | -40.9% | -2.8% |
| March 31, 2024 | -$18.19M | -53.1% | +14.0% |
| September 30, 2023 | -$21.15M | -69.1% | -59.4% |
| June 30, 2023 | -$13.27M | +12.1% | -11.7% |
- Tyra Biosciences, Inc. showed a decrease of -38.7% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Tyra Biosciences, Inc.’s net income has declined by 1184.8% (from -$9.34 million to -$119.95 million).
- The most recent figure is from Tyra Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: